| Interpretable systems biomarkers predict response to immune-checkpoint inhibitors Ó Lapuente-Santana, M van Genderen, PAJ Hilbers, F Finotello, F Eduati Patterns 2 (8), 2021 | 61 | 2021 |
| P08. 06. A Work resumption following lower-grade glioma surgery: a multicenter cohort study IO Kommers, MNG van Genderen, RS Eijgelaar, MG Witte, Y de Haan, ... Neuro-oncology 24 (Suppl 2), ii44, 2022 | 2 | 2022 |
| Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties MNG van Genderen, J Kneppers, A Zaalberg, EM Bekers, AM Bergman, ... npj Systems Biology and Applications 10 (1), 20, 2024 | 1 | 2024 |
| Exploring the onset and progression of prostate cancer through a multicellular agent-based model M Passier, MNG van Genderen, A Zaalberg, J Kneppers, EM Bekers, ... Cancer Research Communications 3 (8), 1473-1485, 2023 | 1 | 2023 |
| OS08. 7. A Depressive symptoms in association with tumor locations at diagnosis in patients with diffuse glioma MNG van Genderen, V Belgers, L Douw, F Barkhof, M Klein, JM Niers, ... Neuro-oncology, 2023 | | 2023 |
| P09. 09A Resection cavity locations associated with changes in depressive symptoms after surgery in patients with diffuse glioma V Belgers, MNG van Genderen, M Cakmak, L Douw, F Barkhof, M Klein, ... Neuro-oncology, 2023 | | 2023 |
